标题
The Versatile Mutational Resistome of Pseudomonas aeruginosa
作者
关键词
-
出版物
Frontiers in Microbiology
Volume 9, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2018-04-13
DOI
10.3389/fmicb.2018.00685
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Constitutive Activation of MexT by Amino Acid Substitutions Results in MexEF-OprN Overproduction in Clinical Isolates of Pseudomonas aeruginosa
- (2018) Paulo Juarez et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Evolution of the Pseudomonas aeruginosa Aminoglycoside Mutational Resistome In Vitro and in the Cystic Fibrosis Setting
- (2018) Carla López-Causapé et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Drug-Driven Phenotypic Convergence Supports Rational Treatment Strategies of Chronic Infections
- (2018) Lejla Imamovic et al. CELL
- Acquired resistance to macrolides in Pseudomonas aeruginosa from cystic fibrosis patients
- (2017) Muhammad-Hariri Mustafa et al. EUROPEAN RESPIRATORY JOURNAL
- Resistance to polymyxins in Gram-negative organisms
- (2017) Katy Jeannot et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Correlation between phenotypic antibiotic susceptibility and the resistome in Pseudomonas aeruginosa
- (2017) Magali Jaillard et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Activity of colistin alone or in combination with rifampicin or meropenem in a carbapenem-resistant bioluminescent Pseudomonas aeruginosa intraperitoneal murine infection model
- (2017) Yun Cai et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Mechanisms leading to in vivo ceftolozane/tazobactam resistance development during the treatment of infections caused by MDR Pseudomonas aeruginosa
- (2017) Pablo A Fraile-Ribot et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Evolved Aztreonam Resistance Is Multifactorial and Can Produce Hypervirulence in Pseudomonas aeruginosa
- (2017) Peter Jorth et al. mBio
- History of antibiotic adaptation influences microbial evolutionary dynamics during subsequent treatment
- (2017) Phillip Yen et al. PLOS BIOLOGY
- Evolution of the Pseudomonas aeruginosa mutational resistome in an international Cystic Fibrosis clone
- (2017) Carla López-Causapé et al. Scientific Reports
- Evolution of Pseudomonas aeruginosa Antimicrobial Resistance and Fitness under Low and High Mutation Rates
- (2016) Gabriel Cabot et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Molecular Epidemiology of Mutations in Antimicrobial Resistance Loci of Pseudomonas aeruginosa Isolates from Airways of Cystic Fibrosis Patients
- (2016) Leonie Greipel et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Dynamics of Mutations during Development of Resistance by Pseudomonas aeruginosa against Five Antibiotics
- (2016) Yanfang Feng et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Penicillin-Binding Protein 3 Is Essential for Growth of Pseudomonas aeruginosa
- (2016) Wei Chen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pyomelanin-producing Pseudomonas aeruginosa selected during chronic infections have a large chromosomal deletion which confers resistance to pyocins
- (2016) Didier Hocquet et al. ENVIRONMENTAL MICROBIOLOGY
- Antibiotic combination therapy can select for broad-spectrum multidrug resistance in Pseudomonas aeruginosa
- (2016) Martin Vestergaard et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Aminoglycoside resistance ofPseudomonas aeruginosain cystic fibrosis results from convergent evolution in themexZgene
- (2016) Michelle H Prickett et al. THORAX
- Mutations in β-Lactamase AmpC Increase Resistance of Pseudomonas aeruginosa Isolates to Antipseudomonal Cephalosporins
- (2015) M. Berrazeg et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The Challenge of Efflux-Mediated Antibiotic Resistance in Gram-Negative Bacteria
- (2015) Xian-Zhi Li et al. CLINICAL MICROBIOLOGY REVIEWS
- The increasing threat of Pseudomonas aeruginosa high-risk clones
- (2015) Antonio Oliver et al. DRUG RESISTANCE UPDATES
- Carbapenem resistance in cystic fibrosis strains of Pseudomonas aeruginosa as a result of amino acid substitutions in porin OprD
- (2015) Charlotte Richardot et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Collateral sensitivity of antibiotic-resistant microbes
- (2015) Csaba Pál et al. TRENDS IN MICROBIOLOGY
- Selective Sweeps and Parallel Pathoadaptation Drive Pseudomonas aeruginosa Evolution in the Cystic Fibrosis Lung
- (2015) Julio Diaz Caballero et al. mBio
- Pseudomonas aeruginosa Ceftolozane-Tazobactam Resistance Development Requires Multiple Mutations Leading to Overexpression and Structural Modification of AmpC
- (2014) Gabriel Cabot et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Avibactam and Class C β-Lactamases: Mechanism of Inhibition, Conservation of the Binding Pocket, and Implications for Resistance
- (2014) S. D. Lahiri et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The Resistome of Pseudomonas aeruginosa in Relationship to Phenotypic Susceptibility
- (2014) Veronica N. Kos et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Epidemiology and carbapenem resistance mechanisms of carbapenem-non-susceptible Pseudomonas aeruginosa collected during 2009-11 in 14 European and Mediterranean countries
- (2014) M. Castanheira et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Environmental Heterogeneity Drives Within-Host Diversification and Evolution of Pseudomonas aeruginosa
- (2014) T. Markussen et al. mBio
- Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria
- (2014) Abiola O. Olaitan et al. Frontiers in Microbiology
- AmgRS-mediated envelope stress-inducible expression of themexXYmultidrug efflux operon ofPseudomonas aeruginosa
- (2014) Calvin Ho-Fung Lau et al. MicrobiologyOpen
- Multiple Mutations Lead to MexXY-OprM-Dependent Aminoglycoside Resistance in Clinical Strains of Pseudomonas aeruginosa
- (2013) Sophie Guénard et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- High-Level Pacidamycin Resistance in Pseudomonas aeruginosa Is Mediated by an Opp Oligopeptide Permease Encoded by theopp-fabIOperon
- (2013) Anita Mistry et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Polymyxin Resistance ofPseudomonas aeruginosa phoQMutants Is Dependent on Additional Two-Component Regulatory Systems
- (2013) Alina D. Gutu et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Mutations and expression of PmrAB and PhoPQ related with colistin resistance in Pseudomonas aeruginosa clinical isolates
- (2013) Ji-Young Lee et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Complexity of resistance mechanisms to imipenem in intensive care unit strains of Pseudomonas aeruginosa
- (2013) Damien Fournier et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Quantitative Contributions of Target Alteration and Decreased Drug Accumulation to Pseudomonas aeruginosa Fluoroquinolone Resistance
- (2012) Sebastian Bruchmann et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Management of ventilator-associated pneumonia: epidemiology, diagnosis and antimicrobial therapy
- (2012) Matteo Bassetti et al. Expert Review of Anti-Infective Therapy
- Genomic Variation among Contemporary Pseudomonas aeruginosa Isolates from Chronically Infected Cystic Fibrosis Patients
- (2012) Jade C. S. Chung et al. JOURNAL OF BACTERIOLOGY
- Antagonistic Interactions of Pseudomonas aeruginosa Antibiotic Resistance Mechanisms in Planktonic but Not Biofilm Growth
- (2011) Xavier Mulet et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- PmrB Mutations Promote Polymyxin Resistance of Pseudomonas aeruginosa Isolated from Colistin-Treated Cystic Fibrosis Patients
- (2011) Samuel M. Moskowitz et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A large sustained endemic outbreak of multiresistant Pseudomonas aeruginosa: a new epidemiological scenario for nosocomial acquisition
- (2011) Cristina Suarez et al. BMC INFECTIOUS DISEASES
- Adaptive resistance to cationic compounds in Pseudomonas aeruginosa
- (2011) Anna Skiada et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- The revival of fosfomycin
- (2011) Argyris S. Michalopoulos et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- A Two-Component Regulatory System Interconnects Resistance to Polymyxins, Aminoglycosides, Fluoroquinolones, and β-Lactams inPseudomonas aeruginosa
- (2010) Cédric Muller et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Genetic Determinants Involved in the Susceptibility of Pseudomonas aeruginosa to -Lactam Antibiotics
- (2010) C. Alvarez-Ortega et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Assessing the Emergence of Resistance: The Absence of Biological Cost In Vivo May Compromise Fosfomycin Treatments for P. aeruginosa Infections
- (2010) Alexandro Rodríguez-Rojas et al. PLoS One
- Structural basis for effectiveness of siderophore-conjugated monocarbams against clinically relevant strains of Pseudomonas aeruginosa
- (2010) S. Han et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Alterations in Two-Component Regulatory Systems of phoPQ and pmrAB Are Associated with Polymyxin B Resistance in Clinical Isolates of Pseudomonas aeruginosa
- (2009) K. Barrow et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Genomewide Identification of Genetic Determinants of Antimicrobial Drug Resistance in Pseudomonas aeruginosa
- (2009) A. Dotsch et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antibacterial-Resistant Pseudomonas aeruginosa: Clinical Impact and Complex Regulation of Chromosomally Encoded Resistance Mechanisms
- (2009) P. D. Lister et al. CLINICAL MICROBIOLOGY REVIEWS
- The Glycerol-3-Phosphate Permease GlpT Is the Only Fosfomycin Transporter in Pseudomonas aeruginosa
- (2009) A. Castaneda-Garcia et al. JOURNAL OF BACTERIOLOGY
- Molecular characterization of Rifr mutations in Pseudomonas aeruginosa and Pseudomonas putida
- (2009) Tatjana Jatsenko et al. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
- β-Lactam Resistance Response Triggered by Inactivation of a Nonessential Penicillin-Binding Protein
- (2009) Bartolomé Moya et al. PLoS Pathogens
- Novel Genetic Determinants of Low-Level Aminoglycoside Resistance in Pseudomonas aeruginosa
- (2008) K. N. Schurek et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The Neglected Intrinsic Resistome of Bacterial Pathogens
- (2008) Alicia Fajardo et al. PLoS One
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started